Follow
Jitinder Singh Wilkhu
Jitinder Singh Wilkhu
PhD in Drug Delivery, Aston University
Verified email at aston.ac.uk
Title
Cited by
Cited by
Year
Microscopy imaging of liposomes: from coverslips to environmental SEM
S Bibi, R Kaur, M Henriksen-Lacey, SE McNeil, J Wilkhu, E Lattmann, ...
International journal of pharmaceutics 417 (1-2), 138-150, 2011
1652011
Characterization and optimization of bilosomes for oral vaccine delivery
JS Wilkhu, SE McNeil, DE Anderson, Y Perrie
Journal of drug targeting 21 (3), 291-299, 2013
792013
The application of monolayer studies in the understanding of liposomal formulations
B Moghaddam, MH Ali, J Wilkhu, DJ Kirby, AR Mohammed, Q Zheng, ...
International journal of pharmaceutics 417 (1-2), 235-244, 2011
712011
Effect of incorporating cholesterol into DDA: TDB liposomal adjuvants on bilayer properties, biodistribution, and immune responses
R Kaur, M Henriksen-Lacey, J Wilkhu, A Devitt, D Christensen, Y Perrie
Molecular pharmaceutics 11 (1), 197-207, 2014
592014
Cannabinoid formulations
J Wilkhu, J Bender
US Patent App. 15/640,033, 2018
432018
Formulation design considerations for oral vaccines
J Wilkhu, SE McNeil, DJ Kirby, Y Perrie
Therapeutic delivery 2 (9), 1141-1164, 2011
432011
Investigating the role of cholesterol in the formation of non-ionic surfactant based bilayer vesicles: thermal analysis and molecular dynamics
JS Wilkhu, D Ouyang, MJ Kirchmeier, DE Anderson, Y Perrie
International journal of pharmaceutics 461 (1-2), 331-341, 2014
372014
Development of a solid dosage platform for the oral delivery of bilayer vesicles
JS Wilkhu, SE McNeil, DE Anderson, M Kirchmeier, Y Perrie
European Journal of Pharmaceutical Sciences 108, 71-77, 2017
252017
Parenteral formulations
S Wright, J Wilkhu
US Patent 11,229,612, 2022
242022
Oral pharmaceutical formulation comprising cannabinoids and poloxamer
J Wilkhu, J Bender
US Patent App. 16/959,357, 2021
232021
Oral cannabinoid formulations
S Wright, J Wilkhu
US Patent 11,426,362, 2022
212022
Modified release composition comprising a cannabinoid
J Wilkhu, J Bender, M Collins
US Patent App. 16/959,354, 2021
202021
Pharmaceutical composition comprising a cannabinoid
J Wilkhu, J Bender
US Patent 11,806,319, 2023
192023
pH dependent release coated microparticle cannabinoid formulations
J Wilkhu, A Silcock
US Patent 11,160,757, 2021
112021
Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines
JS Wilkhu, SE McNeil, DE Anderson, Y Perrie
Drug delivery and translational research 4, 233-245, 2014
112014
Methods for preparing vesicles and formulations produced therefrom
DE Anderson, Y Perrie, M Kirchmeier, JS Wilkhu
US Patent App. 13/979,317, 2013
102013
Non-ionic surfactant technology for the delivery and administration of sub-unit flu antigens
J Wilkhu
Aston University, 2013
72013
Parenteral formulations
S Wright, J Wilkhu
US Patent App. 17/548,232, 2022
62022
Cannabinoid formulations
A Silcock, J Wilkhu
US Patent App. 17/615,422, 2022
42022
Cannabinoid formulations
J Wilkhu, A Silcock
US Patent App. 17/406,401, 2022
32022
The system can't perform the operation now. Try again later.
Articles 1–20